VBCVX
Price
$16.13
Change
+$0.04 (+0.25%)
Updated
Oct 3 closing price
Net Assets
N/A
VVIAX
Price
$73.15
Change
+$0.38 (+0.52%)
Updated
Oct 3 closing price
Net Assets
202.84B
Interact to see
Advertisement

VBCVX vs VVIAX

Header iconVBCVX vs VVIAX Comparison
Open Charts VBCVX vs VVIAXBanner chart's image
VALIC Company I Systematic Value
Price$16.13
Change+$0.04 (+0.25%)
VolumeN/A
Net AssetsN/A
Vanguard Value Index Adm
Price$73.15
Change+$0.38 (+0.52%)
VolumeN/A
Net Assets202.84B
VBCVX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
VBCVX vs. VVIAX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VBCVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX pays higher dividends than VBCVX: VVIAX (2.08) vs VBCVX (1.56). VBCVX was incepted earlier than VVIAX: VBCVX (20 years) vs VVIAX (25 years). VBCVX (0.79) is less costly to investors than VVIAX (0.05). VBCVX is a more actively managed with annual turnover of: 75.00 vs. VVIAX (9.00). VBCVX has a lower initial minimum investment than VVIAX: VBCVX (0) vs VVIAX (3000). VBCVX (8.37) and VVIAX (8.34) have marching annual gain over last year. VVIAX return over 5 years is better than : 79.65 vs. VBCVX (45.75).
VBCVXVVIAXVBCVX / VVIAX
Total Expense Ratio0.650.051,300%
Annual Report Gross Expense Ratio0.790.051,580%
Fund Existence20 years25 years-
Gain YTD9.01810.85283%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A203B-
Annual Yield % from dividends1.562.0875%
Returns for 1 year8.378.34100%
Returns for 3 years41.7344.0495%
Returns for 5 years45.7579.6557%
Returns for 10 years29.20137.1321%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATYR0.780.07
+9.20%
aTyr Pharma Inc
TRC16.190.41
+2.60%
Tejon Ranch Co
BZ23.470.07
+0.30%
Kanzhun Limited
GTBP0.64N/A
-0.05%
GT Biopharma
DXPE126.97-0.66
-0.52%
DXP Enterprises